Dynavax Technologies Corporation (DVAX) Social Stream
DYNAVAX TECHNOLOGIES CORP (DVAX) Price Targets From Analysts
Use the tables below to see what analysts covering DYNAVAX TECHNOLOGIES CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 3 | $30 | $23 | $26.5 | $13.64 | 94.28% |
| 2022-05-09 | 3 | $30 | $28 | $29 | $13.64 | 112.61% |
| 2022-08-08 | 4 | $38 | $28 | $32 | $13.64 | 134.6% |
| 2022-10-20 | 5 | $38 | $22 | $29.5 | $13.64 | 116.28% |
| 2022-11-04 | 5 | $30 | $21 | $25.25 | $13.64 | 85.12% |
| 2023-01-10 | 5 | $28 | $21 | $24 | $13.64 | 75.95% |
| 2023-08-04 | 5 | $27 | $21 | $24.25 | $13.64 | 77.79% |
| 2023-08-07 | 5 | $27 | $21 | $24.5 | $13.64 | 79.62% |
| 2023-09-18 | 4 | $27 | $25 | $25.666 | $13.64 | 88.17% |
The Trend in the Analyst Price Target
DVAX's average price target has moved up $11.67 over the prior 40 months.
DVAX reports an average of 111.36% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-04 | 5 | 30 | 21 | 25.25 | 12.58 | 100.72% |
| 2023-05-03 | 5 | 27 | 21 | 24.50 | 11.02 | 122.32% |
| 2023-05-04 | 5 | 27 | 21 | 24.25 | 10.91 | 122.27% |
| 2023-08-04 | 5 | 27 | 21 | 24.25 | 14.50 | 67.24% |
| 2023-08-07 | 5 | 27 | 21 | 24.50 | 14.75 | 66.1% |
DVAX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 13 months, DVAX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, DYNAVAX TECHNOLOGIES CORP's number of analysts covering the stock is higher than 174.14% of them.
- In terms of how DYNAVAX TECHNOLOGIES CORP fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -57.32% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, DYNAVAX TECHNOLOGIES CORP's upside potential (average analyst target price relative to current price) is greater than 730.57% of them.
- In the context of stocks in the mid market cap category, DYNAVAX TECHNOLOGIES CORP's average analyst price target is higher than 384.74% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to DYNAVAX TECHNOLOGIES CORP are OPK, AMRN, and HRMY.
View All Top Stocks by Price Target
Is DVAX a Buy, Hold or Sell? See the POWR Ratings now!